129 related articles for article (PubMed ID: 6229980)
1. Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.
Christensen SE; Dupont E; Mondrup K; Olivarius BF; Orskov H
Adv Neurol; 1984; 40():325-31. PubMed ID: 6229980
[No Abstract] [Full Text] [Related]
2. Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
Perschak H; Amsler U; Vischer A; Siegfried J; Cuénod M
Hum Neurobiol; 1987; 6(3):191-4. PubMed ID: 2896652
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
[TBL] [Abstract][Full Text] [Related]
4. Involuntary movements other than Parkinsonism: biochemical aspects.
Curzon G
Proc R Soc Med; 1973 Sep; 66(9):873-6. PubMed ID: 4281484
[No Abstract] [Full Text] [Related]
5. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ
Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562
[TBL] [Abstract][Full Text] [Related]
6. [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
Bernheimer H; Birkmayer W; Hornykiewicz O
Wien Klin Wochenschr; 1966 Jun; 78(23):417-9. PubMed ID: 4229554
[No Abstract] [Full Text] [Related]
7. Somatostatin in cerebrospinal fluid.
Cooper PE
Bull Clin Neurosci; 1985; 50():26-9. PubMed ID: 2876739
[No Abstract] [Full Text] [Related]
8. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor.
White LR; Gårseth M; Aasly J; Sonnewald U
J Neurosci Res; 2004 Oct; 78(2):297-301. PubMed ID: 15378514
[TBL] [Abstract][Full Text] [Related]
10. Diazepam binding inhibitor in brain and in cerebrospinal fluid of human.
Ferrero P; Penna P; Vischia F; Tarenzi L; Bergamasco B; Bergamini L
Ann Ist Super Sanita; 1988; 24(3):443-59. PubMed ID: 3190067
[No Abstract] [Full Text] [Related]
11. Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases.
Eder U; Leitner B; Kirchmair R; Pohl P; Jobst KA; Smith AD; Málly J; Benzer A; Riederer P; Reichmann H; Saria A; Winkler H
J Neural Transm (Vienna); 1998; 105(1):39-51. PubMed ID: 9588759
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid choline in extrapyramidal disorders.
Aquilonius SM; Nyström B; Schuberth J; Sundwall A
J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):720-5. PubMed ID: 4263743
[TBL] [Abstract][Full Text] [Related]
13. [Somatostatin and substance P in the cerebrospinal fluid in various neurological diseases].
Harigaya Y; Shoji M; Hirai S; Wakabayashi K
Rinsho Shinkeigaku; 1988 Aug; 28(8):891-6. PubMed ID: 3240626
[No Abstract] [Full Text] [Related]
14. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
Yamamoto M; Otsuki S; Miyake K; Namba R
No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
[No Abstract] [Full Text] [Related]
15. Opposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation.
Bourgoin S; Rostaing-Rigattieri S; Nguyen JP; Berberich E; Duvaldestin P; Fattaccini CM; Hamon M; Cesselin F
Clin Neuropharmacol; 1999; 22(4):231-8. PubMed ID: 10442254
[TBL] [Abstract][Full Text] [Related]
16. A cerebrospinal fluid turnover in Parkinson's disease.
Jamrozik Z; Królicki L; Kwieciński H; Florek M
Mater Med Pol; 1996; 28(3):79-82. PubMed ID: 9167416
[TBL] [Abstract][Full Text] [Related]
17. [Surgical treatment of movement disorders].
Massager N
Rev Med Brux; 2008 Sep; 29(4):248-51. PubMed ID: 18949972
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1374-7. PubMed ID: 2433403
[TBL] [Abstract][Full Text] [Related]
19. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
20. [Qualitative cytology of the cerebrospinal fluid in primary cerebral atrophy].
Kümpel Q; Rýznar J
Cesk Psychiatr; 1970 Oct; 66(5):285-8. PubMed ID: 4249221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
